Tuberculosis and HIV: latest news

Tuberculosis and HIV resources

  • Tuberculosis

    Tuberculosis (TB) is an infection caused by bacteria that usually affects the lungs. With careful treatment it can be cured.TB is the single biggest cause...

    From: Factsheets

    Information level Level 2
  • TB and HIV

    If HIV has weakened your immune system, you are more vulnerable to infection with tuberculosis (TB). TB is an infection caused by bacteria. It is...

    From: The basics

    Information level Level 1
  • Treatment for TB and HIV

    If tuberculosis (TB) is making you ill and you also have HIV, then you usually need to take treatment for both TB and HIV.You can...

    From: The basics

    Information level Level 1
  • Diagnosed with HIV at a low CD4 count

    NAM's factsheet on being diagnosed with HIV when already at a low CD4 cell count...

    From: Factsheets

    Information level Level 2
  • Tuberculosis

    Information on tuberculosis, including symptoms, diagnosis, treatment and interactions with HIV and antiretroviral therapy....

    From: HIV treatments directory

    Information level Level 4
  • HIV & TB

    This booklet gives introductory information about tuberculosis (TB) and how it is treated. ...

    From: Booklets

    Information level Level 2

Tuberculosis and HIV features

Tuberculosis and HIV in your own words

Tuberculosis and HIV news from aidsmap

More news

Tuberculosis and HIV news selected from other sources

  • 'Nine million have TB' - WHO report

    The World Health Organization revises its estimate as to how many people have tuberculosis up by 500,000, in its latest report into the killer disease.

    22 October 2014 | BBC Health
  • 2014 Report on Tuberculosis Research Funding Trends, 2005–2013

    Worldwide, governments, foundations, and companies invested US$676.7 million in research to develop new drugs, vaccines, and diagnostics against tuberculosis (TB) in 2013—barely one-third of the US$2 billion that experts estimate the world must spend each year to end the global TB epidemic—according to an analysis released today by Treatment Action Group (TAG).

    22 October 2014 | TAG
  • Newly identified marker helps predict tuberculosis complications in HIV patients

    An NIAID study suggests that the increased frequency of an immune cell called CD14++CD16- monocyte is a strong indicator that a patient with HIV and tuberculosis (TB) may develop immune reconstitution inflammatory syndrome (IRIS).

    16 October 2014 | National Institute of Allergy and Infectious Diseases (NIAID) press release
  • Isoniazid significantly reduced TB incidence in HIV patients receiving HAART

    The use of isoniazid as preventive therapy among HIV-infected patients receiving highly active antiretroviral therapy (HAART) is associated with significantly lower tuberculosis incidence, reported Bethel Shiferaw, MD, MPH, from Nassau University Medical Center, East Meadow, at IDWeek 2014.

    16 October 2014 | Monthly Prescribing Reference (MPR)
  • In HIV/TB coinfection, initiate antiretroviral therapy early

    Earlier initiation of antiretroviral therapy (ART) significantly lowered mortality in patients with HIV and tuberculosis (TB) co-infection, despite a higher incidence of immune reconstitution inflammatory syndrome (IRIS), according to data presented at 2014 IDWeek.

    16 October 2014 | Monthly Prescribing Reference (MPR)
  • Acquired rifampicin resistance more likely in HIV-coinfected patients

    Patients with HIV and tuberculosis were more likely to develop acquired rifampicin resistance when treated with a thrice-weekly tuberculosis treatment compared with patients not coinfected with HIV, according to researchers from the National Institute for Research in Tuberculosis in India. The rate of bacteriologic failure was 4% among patients without HIV. Among patients with HIV, the rates were 9% for those not receiving ART and 5% for those receiving ART.

    02 September 2014 | Healio
  • U.K. Omitted From Plan to Eliminate TB in Rich Countries

    The U.K. has too big a problem with tuberculosis to participate in a World Health Organization plan to eliminate the world’s second-deadliest disease from more than 30 countries.

    04 July 2014 | Bloomberg
  • Apathy in TB fight: The Economist Intelligence Unit

    A new report on tuberculosis calls for raising the profile of TB, fight apathy and lack of compelling ambition in addressing the disease.

    04 July 2014 | Stop TB Partnership
  • South Africa: Litigation threat may prompt access to cheaper DR-TB drug

    South Africa may finally allow access to a cheaper form of the drug-resistant tuberculosis (DR-TB) drug linezolid following the lodging of a high court case.

    16 June 2014 | Health-e
  • South Africa: Government to introduce new drug-resistant TB drugs

    Government’s small-scale introduction of the first new TB drug in four decades is saving lines and paving the way for more, better and cheaper drugs to treat drug-resistant TB. Many wonder if they will come fast enough for those who need them.

    16 June 2014 | Health-e
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.